Russell Investments Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.4M | Buy |
|
|||||
|
2025
Q1 | $26.6M | Buy |
|
|||||
|
2024
Q4 | $3.92M | Buy |
|
|||||
|
2024
Q3 | $3.2M | Sell |
|
|||||
|
2024
Q2 | $4.75M | Sell |
|
|||||
|
2024
Q1 | $5.68M | Buy |
|
|||||
|
2023
Q4 | $4M | Buy |
|
|||||
|
2023
Q3 | $3.55M | Sell |
|
|||||
|
2023
Q2 | $11M | Sell |
|
|||||
|
2023
Q1 | $24.6M | Sell |
|
|||||
|
2022
Q4 | $30.6M | Buy |
|
|||||
|
2022
Q3 | $20.8M | Buy |
|
|||||
|
2022
Q2 | $7.51M | Buy |
|
|||||
|
2022
Q1 | $2.7M | Sell |
|
|||||
|
2021
Q4 | $3.5M | Sell |
|
|||||
|
2021
Q3 | $3.91M | Buy |
|
|||||
|
2021
Q2 | $3.12M | Buy |
|
|||||
|
2021
Q1 | $2.25M | Sell |
|
|||||
|
2020
Q4 | $4.92M | Sell |
|
|||||
|
2020
Q3 | $4.45M | Sell |
|
|||||
|
2020
Q2 | $9.5M | Buy |
|
|||||
|
2020
Q1 | $1.48M | Sell |
|
|||||
|
2019
Q4 | $1.55M | Hold |
|
|||||
|
2019
Q3 | $1.25M | Sell |
|
|||||
|
2019
Q2 | $4.01M | Buy |
|
|||||
|
2019
Q1 | $3.39M | Buy |
|
|||||
|
2018
Q4 | $2.16M | Sell |
|
|||||
|
2018
Q3 | $3.08M | Sell |
|
|||||
|
2018
Q2 | $4.03M | Buy |
|
|||||
|
2018
Q1 | $2.63M | Sell |
|
|||||
|
2017
Q4 | $9.76M | Sell |
|
|||||
|
2017
Q3 | $21.1M | Buy |
|
|||||
|
2017
Q2 | $3.12M | Sell |
|
|||||
|
2017
Q1 | $10.9M | Buy |
|
|||||
|
2016
Q4 | $2M | Buy |
|